NCT02426632 is a Phase 1 clinical trial of Formulation A in Healthy, sponsored by Janssen Sciences Ireland UC.

Who is sponsoring NCT02426632?

NCT02426632 is sponsored by Janssen Sciences Ireland UC.

What drugs are being tested in NCT02426632?

Interventions in NCT02426632: Formulation A, Formulation B, Formulation C, Formulation D, Formulation E, Formulation F, Formulation M1, Formulation M2, Formulation M3, Formulation N1, Formulation N2, Formulation N3.

Is NCT02426632 still recruiting?

NCT02426632 is currently completed. Last updated 15 May 2018.

Last reviewed 2018-05-15 · How we verify

NCT02426632

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

Completed Phase 1 Last updated 15 May 2018

What this trial tests

Phase 1 trial testing Formulation A in Healthy in 12 participants. Completed in 24 April 2015.

Timeline

4 March 2015

Primary endpoint
24 April 2015

24 April 2015

Quick facts

Lead sponsor	Janssen Sciences Ireland UC
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	other
Enrollment	12
Start date	4 March 2015
Primary completion	24 April 2015
Estimated completion	24 April 2015
Sites	1 location across United Kingdom

Drugs / interventions tested

Formulation A
Formulation B
Formulation C
Formulation D
Formulation E
Formulation F — full drug profile →
Formulation M1 — full drug profile →
Formulation M2 — full drug profile →
Formulation M3 — full drug profile →
Formulation N1
Formulation N2 — full drug profile →
Formulation N3

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Janssen Sciences Ireland UC — full company profile →

Who can join

Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to evaluate in a double-blinded (neither physician nor participant knows the treatment that the participant receives), fashion the taste of different JNJ-53718678 oral liquid formulations as compared to the reference formulation (JNJ-53718678, 10 milligram/milliliter oral solution without sweetener/flavor).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Formulation A

Trials testing the same drug.

NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
NCT03718390 — Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults · EARLY_PHASE1 · completed
NCT03572062 — A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults · Phase 2 · terminated
NCT03529773 — A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults · Phase 2 · completed
NCT00495274 — Bioequivalence and Food Effect Study in Healthy Volunteers · Phase 1 · completed

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Janssen Sciences Ireland UC trials

Trials by the same sponsor.

NCT04208399 — A Study to Evaluate the Effect of Hepatic Impairment on JNJ-56136379 · Phase 1 · completed
NCT04208386 — A Study to Evaluate the Effect of Hepatic Impairment on JNJ-73763989 · Phase 1 · completed
NCT04056611 — Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who A · Phase 2 · terminated
NCT04129554 — A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virolo · Phase 2 · completed
NCT03982186 — A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepati · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02426632 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Janssen Sciences Ireland UC
Last refreshed: 15 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02426632.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing